or
forgot password
  • cancer clinical trials in houston, TX

  • Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Familial Adenomatous Polyposis, Colorectal Cancer
    Brachytherapy for Prostatic Carcinoma Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Leukemia, Myelodysplastic Syndrome
    Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Stomach Cancer, Gastric Cancer
    Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Gastrointestinal Diseases
    Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Pancreatic Cancer
    Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    M D Anderson Cancer Center
    Houston, Texas 77030
    Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    MD Anderson - University of Texas
    Houston, Texas 77030
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Multiple Myeloma
    Valproic Acid and Bevacizumab in Patients With Advanced Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancer
    4-Dimensional CT Derived Ventilation Versus SPECT Aerosol Ventilation in Patients With Thoracic Malignancies
    U.T.M.D. Anderson Cancer Center
    Houston, Texas 77030
    Esophageal Cancer, Lung Cancer
    Early Detection of Cardiotoxicity During Sunitinib or Sorafenib Chemotherapy Using Cardiac Biomarkers
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancers
    Weight Gain Prevention for Breast Cancer Survivors
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lung Cancer
    Neuropathic Pain in Survivors of Breast Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Hyperparathyroidism
    Early Detection of Ovarian Cancer
    UT MD Anderson Cancer Center

    Trial Locations
    UT MD Anderson Cancer Center
    University of Texas Physicians-Family Practice Associates
    Ovarian Cancer
    Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
    Texas Children's Hospital

    Trial Locations
    Texas Children's Hospital
    The Methodist Hospital
    Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorder, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Non-malignant Diseases Requiring Allogeneic HSCT
    Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Bevacizumab in Multiple Phase I Combinations
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Advanced Cancer
    Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Liver Cancer
    Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Rectal Cancer
    Lapatinib and Trastuzumab With or Without Endocrine Therapy
    Baylor College of Medicine, Lester and Sue Smith Breast Center
    Houston, Texas 77030
    Breast Cancer
    Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Brain Cancer
    Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
    M. D. Anderson Cancer Center at University of Texas
    Houston, Texas 77030-4009
    Leukemia
    Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
    M D Anderson Cancer Center
    Houston, Texas 77030
    Borderline Ovarian Surface Epithelial-stromal Tumor, Ovarian Serous Cystadenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor
    Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
    University of Texas M.D. Anderson CCOP Research Base
    Houston, Texas 77030-4009
    Chemotherapy-induced Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma
    Baylor College of Medicine

    Trial Locations
    Baylor College of Medicine
    M D Anderson Cancer Center
    Extraocular Retinoblastoma
    Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Glioblastoma Multiforme, Anaplastic Glioma
    Meditation and Cognitive Function in Women With Breast Cancer
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Breast Cancer
    Role of Methadone As Co-Opioid Analgesic
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Pain
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    M.D. Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    Quality of Life Study for Prostate Cancer Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Prostate Cancer
    CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
    MD Anderson Cancer Center
    Houston, Texas 77030-4096
    Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
    Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia
    M D Anderson Cancer Center
    Houston, Texas 77030
    Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia
    TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Non-Small Cell Lung Cancer, Lung Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Methodist Hospital

    Trial Locations
    Methodist Hospital
    M D Anderson Cancer Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Vaccine Study for Surgically Resected Pancreatic Cancer
    Baylor College of Medicine
    Houston, Texas 77030
    Pancreatic Cancer
    Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
    Baylor College of Medicine
    Houston, Texas 77030
    Breast Cancer
    Combined Treatment for Tobacco and Alcohol Use in Puerto Rico
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Smoking
    Brain Mets - Capecitabine and WBRT
    Lester and Sue Smith Breast Center at Baylor College of Medicine
    Houston, Texas 77030
    Breast Cancer
    Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
    The University of Texas M. D. Anderson Cancer Center
    Houston, Texas 77030
    Estrogen Receptor-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
    UT MD Anderson Cancer Center
    Houston, Texas 77030
    Lymphoma
    T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
    Texas Children's Hospital
    Houston, Texas
    Leukemia, Cancer, Lymphoma, Lymphoma, Hodgkin, Lymphoma, Non-Hodgkin
    Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
    Texas Children's Hospital
    Houston, Texas
    Neuroblastoma
    Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
    Pfizer Investigational Site
    Houston, Texas 77030
    Adenomatous Polyposis Coli
    CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
    Methodist Hospital

    Trial Locations
    Methodist Hospital
    Texas Children's Hospital
    B Cell Lymphoma, Chronic Lymphocytic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Ben Taub General Hospital

    Trial Locations
    Ben Taub General Hospital
    Methodist Hospital
    Veterans Administration Medical Center
    Saint Luke's Episcopal Hospital
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary